The State of the Centrifuge Industry
Laboratory centrifuges are a technically mature category whose market structure is shifting. For the past decade, import substitution happened mainly in routine "good enough" applications; in recent years the change has moved to the mid-range — academic research, clinical testing and biopharma pilot production — where domestic brands keep gaining share.
Three forces
First, supply-chain localisation. The three core parts are the motor, the rotor and the control system. Brushless inverter motors are now reliably sourced domestically, and the rotor chain from five-axis milling to dynamic balancing is essentially complete; as local content rises, lead times have compressed from months to weeks.
Second, service radius. A centrifuge is not a buy-and-forget device: rotors need verification, seals need replacing, bearings need checking. Imported brands concentrate service in a few major cities, with cross-province response measured in weeks; domestic manufacturers with sites in Shanghai, Beijing, Guangzhou, Changsha and Chengdu respond in days. For continuously running clinical laboratories and production lines, that matters more than a specification difference.
Third, specifications are becoming public. More buyers now require speed, RCF, capacity, noise and temperature range to be written into tender documents and verified item by item rather than trusting a brochure. Once specifications can be checked, pricing based on information asymmetry disappears.
What has not been replaced
To be objective: ultracentrifuges (in the 100,000 r/min class) and some very large-capacity and continuous-flow models remain dominated by imported equipment. The barrier there is not assembly but materials, rotor fatigue-life calculation and accumulated long-term operating data. Domestic manufacturers currently compete in the 3,000–21,000 r/min range — precisely where the vast majority of daily laboratory separation happens.
That range is not "low-end". Nucleic acid and protein extraction, subcellular fractionation, blood product processing and routine clinical separation almost all fall inside it. Doing this segment well covers far more real work than the handful of ultracentrifuge applications.
Buyers evaluate differently now
The clearest change is the shift from unit price to total cost of ownership. Purchase prices for a benchtop high-speed unit may differ by 20–30%, but rotor replacement, seals, bearing maintenance and downtime over five years often erase or even reverse that gap. Evaluation sheets now include items that were never there before: spare-parts pricing, response-time commitments, and whether operator training is provided.
For manufacturers this shifts the focus from writing impressive specifications to making them real and putting service close by. It is why MRK writes five sales centers, two years of free repair and lifetime maintenance after the warranty into its standard service terms.